Hirose Takahisa
Department of Medicine, Metabolism and Endocrinology, Juntendo University School of Medicine.
Nihon Rinsho. 2005 Dec;63(12):2237-44.
The mechanisms by which postprandial hyperglycemia is elicited were discussed through therapies of type 2 diabetes using "glinides". It has been believed that the earliest determinant of progression to type 2 diabetes is a loss of early insulin secretion, a defect which results in postprandial hyperglycemia and is often believed to reflect insulin resistance. To prove that, we improved insulin secretion pattern without increase of total amount of insulin secretion using glinide and assessed glucose response. Glinide which selectively enhances early meal-induced insulin secretion improved postprandial hyperglycemia, could provide a valuable treatment option in the prevention and treatment of type 2 diabetes.
通过使用“格列奈类”药物治疗2型糖尿病,探讨了餐后高血糖发生的机制。人们一直认为,进展为2型糖尿病的最早决定因素是早期胰岛素分泌丧失,这一缺陷会导致餐后高血糖,并且通常认为这反映了胰岛素抵抗。为了证实这一点,我们使用格列奈类药物在不增加胰岛素分泌总量的情况下改善胰岛素分泌模式,并评估葡萄糖反应。选择性增强早餐饮食诱导胰岛素分泌的格列奈类药物改善了餐后高血糖,可为2型糖尿病的预防和治疗提供有价值的治疗选择。